FIELD: medicine. SUBSTANCE: medicinal agent has 3-(α-L-arabinopyranosyl-1)-1-methyl-1-nitrosourea, polyvinylpyrrolidone, sorbic acid and water for injection or 5% glucose solution taken at the definite ratio of components. EFFECT: enhanced effectiveness of agent.
Title | Year | Author | Number |
---|---|---|---|
ANTITUMOR AGENT | 1980 |
|
SU1834006A1 |
METHOD FOR TREATING GENERALIZED SKIN MELANOMA | 2005 |
|
RU2301061C2 |
METHOD FOR APPLYING COMBINED SKIN MELANOMA TREATMENT | 2006 |
|
RU2312687C1 |
APPLICATION OF FUNGICIDE AS AGENT FOR TREATING ONCOLOGIC DISEASES | 2007 |
|
RU2381027C2 |
METHOD OF PREDICTING OUTCOME OF ADVANCED CUTANEOUS MELANOMA DURING THERAPY WITH CHECKPOINT INHIBITORS | 2023 |
|
RU2810433C1 |
METHOD OF IMMUNOTHERAPY WITH BONE-MARROW PRECURSORS OF DENDRITE CELLS, SENSIBILISED WITH PHOTOMODIFIED TUMOR CELLS IN VIVO, FOR PATIENTS DISSEMINATED WITH SOLID TUMORS | 2008 |
|
RU2376033C1 |
METHOD OF TREATING ONCOLOGICAL PATIENTS WITH CYTOTOXIC LYMPHOCYTES | 2015 |
|
RU2596505C1 |
METHOD OF SKIN MELANOMA TREATMENT | 0 |
|
SU1790408A3 |
METHOD FOR TREATING THE CASES OF KAPOSI SARCOMA | 1996 |
|
RU2130773C1 |
METHOD FOR TREATMENT OF MALIGNANT NEOPLASMS | 2003 |
|
RU2257899C1 |
Authors
Dates
1995-04-20—Published
1989-03-06—Filed